PMID: 11902500Mar 21, 2002Paper

Human recombinant erythropoietin and quality of life: a wonder drug or something to wonder about?

The Lancet Oncology
Andrew BottomleyBenjamin Djulbegovic

Abstract

Over the past decade an increasing number of studies have supported the use of recombinant human erythropoietin (epoetin) in cancer patients, suggesting that it improves haemoglobin concentrations for some. There is also evidence that this treatment may lead to improvement in quality of life for cancer patients. This systematic review examines the issue. We identified and critically reviewed 13 trials. Although some of the results indicate that epoetin has positive effects on quality of life, methodological limitations inherent in most of the studies hamper interpretation of data. Evidence from this review suggests that more robust designs are required to show any significant quality-of-life benefits for cancer patients undergoing epoetin treatment.

References

Apr 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D A RevickiR L Benz
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T GamucciF Calabresi
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R Abels
May 19, 1993·Journal of the National Cancer Institute·D C CaseC R Nichols
Apr 1, 1993·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·G I Ringdal, K Ringdal
Jan 1, 1996·Journal of Clinical Epidemiology·C BouchetS Briançon
Feb 1, 1996·Transfusion·K BensonG H Lyman
Feb 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·S M GrunbergB Meyerowitz
Oct 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M StaquetD Machin
Oct 30, 1998·European Journal of Cancer Care·A Bottomley
Oct 31, 1998·BMJ : British Medical Journal·C SandersS Frankel
Aug 24, 1999·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·K RingdalM J Hjermstad

❮ Previous
Next ❯

Citations

Jan 1, 2003·Environmental Health and Preventive Medicine·Laurie Feldman, Arthur J Sytkowski
Jan 18, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·J KallichD Cella
Sep 3, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F Efficace, A Bottomley
Mar 8, 2006·Nature Clinical Practice. Oncology·Julia BohliusAndreas Engert
Apr 7, 2005·Journal of the National Cancer Institute·Julia BohliusAndreas Engert
Jun 17, 2010·Journal of the National Cancer Institute·Kathrin BauerAndreas Engert
May 14, 2009·Therapeutics and Clinical Risk Management·Iain Rj MacphersonNicholas S Reed
Oct 8, 2004·Internal Medicine·Wolfgang Jelkmann
Sep 10, 2002·The Lancet Oncology·Andrew BottomleyBenjamin Djulbegovic
Jul 31, 2002·The Lancet Oncology·Timothy J LittlewoodUNKNOWN Epoetin Alfa Study Group
May 7, 2003·The Lancet Oncology·Ambuj KumarBenjamin Djulbegovic
Aug 24, 2004·Annals of Hematology·Wolfgang Jelkmann, Klaus Wagner
Jul 27, 2010·PM & R : the Journal of Injury, Function, and Rehabilitation·Sandra A Mitchell
Jul 16, 2008·Leukemia Research·Domenico Ribatti
Apr 3, 2003·British Journal of Haematology·Jens Samol, Timothy J Littlewood
Apr 20, 2007·Clinical Journal of Oncology Nursing·Sandra A MitchellEllen R Tanner
Jul 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew BottomleySam H Ahmedzai
May 31, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew BottomleyAlexander de Graeff
Jul 17, 2007·Seminars in Hematology·Gernot Beutel, Arnold Ganser
Apr 6, 2006·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·M Milano, R Collomp
Dec 14, 2012·The Cochrane Database of Systematic Reviews·Thomy ToniaJulia Bohlius
Jul 10, 2009·The Cochrane Database of Systematic Reviews·Julia BohliusAndreas Engert
Sep 25, 2002·BMC Cancer·Otavio ClarkBenjamin Djulbegovic
Oct 13, 2006·The Cancer Journal·Sandra A Mitchell, Ann M Berger
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elisabet LindholmKent Lundholm
Jun 17, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Engert
Apr 25, 2008·Critical Reviews in Oncology/hematology·Wolfgang JelkmannArthur J Sytkowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Expert Review of Anticancer Therapy
Timothy J Littlewood, Graham Collins
The Lancet Oncology
Timothy J LittlewoodEpoetin Alfa Study Group
Cyberpsychology & Behavior : the Impact of the Internet, Multimedia and Virtual Reality on Behavior and Society
H OyamaN Katsumata
Journal of Pain and Symptom Management
Augusto Caraceni, Fabio Simonetti
Journal of Hematotherapy & Stem Cell Research
A Oda, K I Sawada
© 2022 Meta ULC. All rights reserved